Postacute psychological symptoms related to the use of classic psychedelics: A qualitative study on help-seeking experiences

A subset of individuals report enduring psychological symptoms following the use of classic psychedelics such as LSD, psilocybin, or mescaline, which persist well beyond the substances’ acute pharmacological effects and may substantially impair daily functioning. Despite the growing enthusiasm for psychedelic-assisted therapies, little is known about individuals who experience prolonged adverse psychological reactions after psychedelic use. This qualitative study explores how societal, medical, and media discourses surrounding psychedelics shape the lived experiences of affected individuals - particularly in the context of seeking help.

Thirteen semi-structured interviews with participants diagnosed with persistent psychedelic-associated psychological disorders were analyzed using reflexive thematic analysis. The results illustrate how idealized portrayals of psychedelics in media and scientific discourse initially function as motivational drivers for consumption. However, when distressing symptoms arise, participants often encounter stigmatization, disbelief, and epistemic invalidation - both socially and within the medical system. The help-seeking process is thus situated within a web of contradictory narratives: psychedelics are celebrated as “healing tools” yet simultaneously stigmatized as illicit drugs. This duality contributes to a fragmented experience of care and an enduring sense of marginalization.

The study concludes that current therapeutic and societal frameworks lack appropriate language and conceptual models to meaningfully integrate negative psychedelic experiences and persisting psychedelic-associated psychological symptoms. It advocates for an interdisciplinary, experience-informed approach that recognizes those symptoms as legitimate phenomena requiring differentiated medical and psychosocial support.